Morgan Stanley - Dec 31, 2024 SCHEDULE 13G Report for Sage Therapeutics, Inc. Common Stock (SAGE)

Filing Manager
MORGAN STANLEY
Reporting Manager
Morgan Stanley
Security
Sage Therapeutics, Inc. Common Stock
Symbol
SAGE
Shares outstanding
61.4M shares
Disclosed Ownership
4.54M shares
Ownership
7.4%
Form type
SCHEDULE 13G
Date filed
2/5/2025, 10:41 AM
Date of event
Dec 31, 2024
Next filing
Mar 6, 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Morgan Stanley 7.4% 4.54M 0 4.44M Christopher O'Hara Authorized Signatory, Morgan Stanley
Morgan Stanley & Co. LLC 5.5% 3.39M 0 3.39M Christopher O'Hara Authorized Signatory, Morgan Stanley & Co. LLC